ADMA Biologics Inc ADMA

9.38 (0.14) (1.47%) as of 25 Sep
Market cap
$2.1B
P/E
13.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
29.90 20.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
8.52 9.37 3.95 4.97 2.43 3.98 7.41 6.36 3.32 5.68
P/FCF ratio
158.03 36.31 252.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
121.96 79.60 57.91 (103.78) (5.88) (5.21) (11.06) (5.75) (5.66) (16.75)
P/B ratio
9.11 11.45 7.54 5.04 1.39 1.90 8.30 5.46 1.87 0.00
Price to Tangible BV
9.19 11.59 7.77 5.19 1.45 2.04 11.15 8.83 2.36 0.00
EV/Sales
8.50 9.32 4.30 5.41 3.07 4.97 9.38 7.46 3.19 5.40
EV/EBITDA
21.67 26.90 34.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
86.04 33.51 126.03 (14.01) (2.21) (2.06) (3.61) (2.02) (1.95) (3.15)
EV/FCF
157.64 36.11 275.28 (11.36) (1.98) (1.83) (3.44) (1.96) (1.82) (3.14)
Quick Ratio
3.54 2.76 1.58 2.60 2.62 3.47 2.15 2.51 4.98 1.45
Current Ratio
6.71 5.97 5.16 6.89 6.87 7.71 6.12 4.63 6.60 1.93
Net Debt/EBITDA
(0.06) (0.15) 2.75 (2.26) (1.01) (0.70) (1.56) (0.33) 0.08 (0.19)
Debt/Assets
12.17% 16.55% 42.64% 44.32% 37.26% 47.03% 66.67% 46.65% 37.23% 77.89%
Debt/Equity
0.16 0.23 1.04 1.02 0.73 1.11 3.23 2.10 1.00 (4.14)
Asset Turnover
0.92 1.04 0.76 0.49 0.33 0.25 0.27 0.17 0.35 0.45
Operating CF/Net income
0.34 0.60 (0.31) 0.90 1.57 1.35 1.58 0.95 0.85 0.94
Capex/Depreciation
(2.64) (0.97) (0.46) (1.48) (1.86) (2.28) (0.89) (0.48) (0.80) (0.07)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
35.56% 81.65% (19.67%) (44.96%) (62.46%) (132.38%) (210.08%) (218.77%) (243.95%) 1,073.35%
ROA
26.40% 48.34% (8.33%) (21.10%) (29.61%) (45.25%) (44.71%) (66.78%) (66.45%) (82.34%)
ROIC
25.69% 26.58% 6.03% (11.19%) (18.90%) (31.21%) (30.76%) (97.92%) (65.63%) 0.00%
Return on Tangible Assets
31.80% 59.80% (10.82%) (22.77%) (31.25%) (43.19%) (46.63%) (101.11%) (52.49%) (156.94%)
Average Days of Receivables
113.35 42.79 38.76 36.73 128.86 114.44 43.15 29.92 62.22 34.85
Research and Development Expense of Revenue
0.93% 0.43% 1.28% 2.35% 4.50% 13.99% 7.99% 23.11% 24.47% 72.12%
Selling, General and Administrative Expense of Revenue
17.95% 17.38% 22.86% 34.05% 53.00% 83.02% 88.28% 132.48% 82.39% 79.68%
Intangible Assets out of Total Assets
0.01 0.01 0.01 0.01 0.02 0.03 0.05 0.08 0.08 0.00
Share Based Compensation of Revenue
3.93% 3.19% 2.40% 3.38% 4.31% 6.76% 9.03% 13.09% 6.86% 11.73%
Graham Net Nets
0.07 0.05 0.06 0.10 0.37 0.20 (0.07) (0.23) (0.07) (0.11)
Graham Number
5.24 5.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.66
Earnings Yield
3.34% 4.90% (2.86%) (8.79%) (37.59%) (45.13%) (22.50%) (61.09%) (57.26%) (32.53%)
Free Cash Flow Yield
0.63% 2.75% 0.40% (9.59%) (63.96%) (68.30%) (36.80%) (59.98%) (52.87%) (30.31%)
Revenue per Share
2.14 1.83 1.15 0.78 0.58 0.49 0.54 0.38 0.99 0.88
Operating CF per Share
0.21 0.51 0.04 (0.30) (0.81) (1.18) (1.40) (1.39) (1.63) (1.50)
Capex per Share
(0.10) (0.04) (0.02) (0.07) (0.10) (0.15) (0.07) (0.05) (0.12) (0.01)
Free Cash Flow per Share
0.12 0.47 0.02 (0.37) (0.90) (1.33) (1.47) (1.43) (1.74) (1.51)
Cash per Share
0.37 0.44 0.23 0.44 0.37 0.65 0.49 0.50 1.88 1.26
Shareholders Equity per Share
2.00 1.50 0.60 0.77 1.01 1.02 0.48 0.44 1.76 (0.37)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
2.00 1.50 0.60 0.77 1.01 1.02 0.48 0.44 1.76 (0.37)
Free Cash Flow
27.51 110.10 3.82 (73.42) (125.88) (114.73) (80.01) (64.77) (39.95) (18.34)
Working Capital
396.97 275.87 207.21 231.14 178.35 133.79 71.79 34.90 52.90 10.43
Capital Expenditures
(22.89) (8.57) (4.98) (13.91) (13.51) (12.72) (3.81) (2.10) (2.68) (0.07)
Net Current Asset Value
319.59 191.75 63.04 73.92 73.65 34.32 (15.08) (24.58) (5.34) (6.49)
EV/EBIT
22.65 28.61 51.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.04 0.02 0.02 0.09 0.17 0.30 0.13 0.12 0.12 0.01
Net Profit Margin
28.80% 46.35% (10.94%) (42.77%) (88.52%) (179.41%) (164.50%) (387.06%) (192.26%) (183.05%)
Price to Operating Income
22.70 28.76 47.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.13 0.16 0.20 0.16 0.14 0.13 0.14 0.15 0.11 0.50
Cash ROIC
(2.29%) 12.00% (13.78%) (29.97%) (55.32%) (59.38%) (78.40%) (110.48%) (54.78%) (69.19%)
Accounts Receivable Turnover
4.90 11.02 12.03 6.99 3.87 5.05 12.07 6.44 9.29 10.98
Accounts Payable Turnover
10.17 11.53 11.72 9.26 6.79 6.05 5.24 7.14 6.87 2.73
Inventory Turnover
1.15 1.21 1.01 0.83 0.77 0.91 1.10 2.70 3.31 1.50
Average Days of Payables
37.81 35.67 33.77 40.64 56.87 65.95 84.77 51.04 74.10 147.17
Days of Inventory on Hand
346.63 300.32 372.83 501.60 570.69 485.56 490.29 161.04 158.05 288.07
Average Receivables
104.21 38.71 21.46 22.04 20.91 8.35 2.43 2.64 2.45 0.97
Average Payables
21.37 17.94 14.44 12.83 11.75 10.12 7.54 5.91 4.24 2.33
Average Inventory
188.35 171.57 168.09 144.00 103.13 67.30 35.84 15.62 8.82 4.23
Average Assets
556.46 408.93 338.82 312.36 241.96 167.38 107.98 98.45 65.85 23.70
Average Common Equity
413.17 242.11 143.59 146.57 114.71 57.22 22.98 30.05 17.94 (1.82)

Fold the line items

Columns are period end dates